494 related articles for article (PubMed ID: 24244584)
1. Early decline in glucose transport and metabolism precedes shift to ketogenic system in female aging and Alzheimer's mouse brain: implication for bioenergetic intervention.
Ding F; Yao J; Rettberg JR; Chen S; Brinton RD
PLoS One; 2013; 8(11):e79977. PubMed ID: 24244584
[TBL] [Abstract][Full Text] [Related]
2. Decline in mitochondrial bioenergetics and shift to ketogenic profile in brain during reproductive senescence.
Yao J; Hamilton RT; Cadenas E; Brinton RD
Biochim Biophys Acta; 2010 Oct; 1800(10):1121-6. PubMed ID: 20538040
[TBL] [Abstract][Full Text] [Related]
3. Ovariectomy induces a shift in fuel availability and metabolism in the hippocampus of the female transgenic model of familial Alzheimer's.
Ding F; Yao J; Zhao L; Mao Z; Chen S; Brinton RD
PLoS One; 2013; 8(3):e59825. PubMed ID: 23555795
[TBL] [Abstract][Full Text] [Related]
4. White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease.
Klosinski LP; Yao J; Yin F; Fonteh AN; Harrington MG; Christensen TA; Trushina E; Brinton RD
EBioMedicine; 2015 Dec; 2(12):1888-904. PubMed ID: 26844268
[TBL] [Abstract][Full Text] [Related]
5. 2-Deoxy-D-glucose treatment induces ketogenesis, sustains mitochondrial function, and reduces pathology in female mouse model of Alzheimer's disease.
Yao J; Chen S; Mao Z; Cadenas E; Brinton RD
PLoS One; 2011; 6(7):e21788. PubMed ID: 21747957
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease.
Yao J; Irwin RW; Zhao L; Nilsen J; Hamilton RT; Brinton RD
Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14670-5. PubMed ID: 19667196
[TBL] [Abstract][Full Text] [Related]
7. Human ApoE Isoforms Differentially Modulate Brain Glucose and Ketone Body Metabolism: Implications for Alzheimer's Disease Risk Reduction and Early Intervention.
Wu L; Zhang X; Zhao L
J Neurosci; 2018 Jul; 38(30):6665-6681. PubMed ID: 29967007
[TBL] [Abstract][Full Text] [Related]
8. Developmental switch in brain nutrient transporter expression in the rat.
Vannucci SJ; Simpson IA
Am J Physiol Endocrinol Metab; 2003 Nov; 285(5):E1127-34. PubMed ID: 14534079
[TBL] [Abstract][Full Text] [Related]
9. Effects of a dietary ketone ester on hippocampal glycolytic and tricarboxylic acid cycle intermediates and amino acids in a 3xTgAD mouse model of Alzheimer's disease.
Pawlosky RJ; Kemper MF; Kashiwaya Y; King MT; Mattson MP; Veech RL
J Neurochem; 2017 Apr; 141(2):195-207. PubMed ID: 28099989
[TBL] [Abstract][Full Text] [Related]
10. A unifying hypothesis of Alzheimer's disease. IV. Causation and sequence of events.
Heininger K
Rev Neurosci; 2000; 11 Spec No():213-328. PubMed ID: 11065271
[TBL] [Abstract][Full Text] [Related]
11. Reduction of epileptiform activity in ketogenic mice: The role of monocarboxylate transporters.
Forero-Quintero LS; Deitmer JW; Becker HM
Sci Rep; 2017 Jul; 7(1):4900. PubMed ID: 28687765
[TBL] [Abstract][Full Text] [Related]
12. Shift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventions.
Yao J; Rettberg JR; Klosinski LP; Cadenas E; Brinton RD
Mol Aspects Med; 2011 Aug; 32(4-6):247-57. PubMed ID: 22024249
[TBL] [Abstract][Full Text] [Related]
13. Ketogenic diet improves motor performance but not cognition in two mouse models of Alzheimer's pathology.
Brownlow ML; Benner L; D'Agostino D; Gordon MN; Morgan D
PLoS One; 2013; 8(9):e75713. PubMed ID: 24069439
[TBL] [Abstract][Full Text] [Related]
14. Hippocampal disruptions of synaptic and astrocyte metabolism are primary events of early amyloid pathology in the 5xFAD mouse model of Alzheimer's disease.
Andersen JV; Skotte NH; Christensen SK; Polli FS; Shabani M; Markussen KH; Haukedal H; Westi EW; Diaz-delCastillo M; Sun RC; Kohlmeier KA; Schousboe A; Gentry MS; Tanila H; Freude KK; Aldana BI; Mann M; Waagepetersen HS
Cell Death Dis; 2021 Oct; 12(11):954. PubMed ID: 34657143
[TBL] [Abstract][Full Text] [Related]
15. Ovarian hormone loss induces bioenergetic deficits and mitochondrial β-amyloid.
Yao J; Irwin R; Chen S; Hamilton R; Cadenas E; Brinton RD
Neurobiol Aging; 2012 Aug; 33(8):1507-21. PubMed ID: 21514693
[TBL] [Abstract][Full Text] [Related]
16. Brain glucose and ketone utilization in brain aging and neurodegenerative diseases.
Kapogiannis D; Avgerinos KI
Int Rev Neurobiol; 2020; 154():79-110. PubMed ID: 32739015
[TBL] [Abstract][Full Text] [Related]
17. Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using
Li XY; Men WW; Zhu H; Lei JF; Zuo FX; Wang ZJ; Zhu ZH; Bao XJ; Wang RZ
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27763550
[TBL] [Abstract][Full Text] [Related]
18. Midlife Chronological and Endocrinological Transitions in Brain Metabolism: System Biology Basis for Increased Alzheimer's Risk in Female Brain.
Wang Y; Shang Y; Mishra A; Bacon E; Yin F; Brinton R
Sci Rep; 2020 May; 10(1):8528. PubMed ID: 32444841
[TBL] [Abstract][Full Text] [Related]
19. Effects of Ketone Bodies on Brain Metabolism and Function in Neurodegenerative Diseases.
Jensen NJ; Wodschow HZ; Nilsson M; Rungby J
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233502
[TBL] [Abstract][Full Text] [Related]
20. A Dietary Ketone Ester Normalizes Abnormal Behavior in a Mouse Model of Alzheimer's Disease.
Pawlosky RJ; Kashiwaya Y; King MT; Veech RL
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32033248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
